Dolutegravir 25 mg and 50 mg and Oxymorphone Extended-Release Tablets
Determining the interaction of Dolutegravir 25 mg and 50 mg and Oxymorphone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir 25 mg and 50 mg-Oxymorphone Hydrochloride
- Dolutegravir 25 mg and 50 mg-Oxymorphone Injection
- Dolutegravir 25 mg and 50 mg-Oxymorphone Tablets
- Dolutegravir 25 mg and 50 mg-Oxytocin
- Dolutegravir 25 mg and 50 mg-Oxytocin Intravenous, Intramuscular
- Dolutegravir 25 mg and 50 mg-Oxytrol
- Oxymorphone Extended-Release Tablets-Dolutegravir and lamivudine
- Oxymorphone Extended-Release Tablets-Dolutegravir and rilpivirine
- Oxymorphone Extended-Release Tablets-Dolutegravir Sodium
- Oxymorphone Extended-Release Tablets-Dolutegravir Sodium And Lamivudine
- Oxymorphone Extended-Release Tablets-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Oxymorphone Extended-Release Tablets-Dom-Etoposide